scholarly journals Mitral valve replacement with Alvarez prosthesis: long-term results

Thorax ◽  
1969 ◽  
Vol 24 (3) ◽  
pp. 287-290 ◽  
Author(s):  
Y. A. S. Mashhour ◽  
J. B. Garcia ◽  
M. Ionescu ◽  
G. H. Wooler
Author(s):  
N. Shikhverdiev ◽  
G. Khubulava ◽  
S. Marchenko ◽  
M. Askerov

The types of surgical correction of the mitral valve pathology, hospital and long-term results were studied. The mitral valve repair being compared to the mitral valve replacement is procedure of choice as it provides stable results. In the study we demonstrate that the long-term results of reconstructive procedures on the mitral valve have advantages over mitral valve replacement in terms of survival, freedom from reoperation and tromboembolc complications.


2019 ◽  
Vol 3 (Issue 2) ◽  
pp. 50
Author(s):  
Dinara Toktosunova

Complete preservation of leaflets for mitral valve replacement to maintain geometry and the function of left ventricle in the near and distant period is necessary. The aim of study was to analyze these procedures. Bileaflet preservation of the anatomical architectonics of the left ventricle in combination with the surgical reduction of the enlarged left atrium will allow to optimize the postoperative geometry and to improve the remodeling of all the left heart along with improved long-term results of patients with mitral valve replacement.


2003 ◽  
Vol 75 (3) ◽  
pp. 826-829 ◽  
Author(s):  
Ryuji Higashita ◽  
Seiichi Ichikawa ◽  
Hiroshi Niinami ◽  
Tetsuo Ban ◽  
Yuji Suda ◽  
...  

2003 ◽  
Vol 6 (1) ◽  
pp. 30-36 ◽  
Author(s):  
H. Yao ◽  
T. Miyamoto ◽  
S. Mukai ◽  
M. Yamamura ◽  
H. Tanaka ◽  
...  

Author(s):  
G. Pappas ◽  
D. H. Davies ◽  
S. G. Blount ◽  
J. H. K. Vogel ◽  
B. C. Paton ◽  
...  

2018 ◽  
Vol 7 (2) ◽  
pp. 61-70
Author(s):  
S. I. Babenko ◽  
N. N. Soboleva ◽  
N. P. Bakuleva ◽  
D. A. Titov ◽  
R. M. Muratov

Background Heart valve replacement with mechanical prostheses in elderly patients is associated with increased risk of bleeding due to the need of lifelong indirect anticoagulant therapy. Therefore, biological heart valve prosthesis is an option of choice. Aim To estimate long-term results of aortic and mitral valve replacement with xenopericardial prosthesis «BioLAB». Methods 150 stented biological prostheses «BioLAB» were implanted into the aortic and mitral position in the Department of Emergency Surgery for Acquired Heart Disease in the period from January 1993 to December 2008. 50 stentless biological prostheses «BioLAB» were implanted in the aortic position in the period from January 2008 to December 2012. Results 1-, 5- and 10-years survival in the recipients of stented xenopericardial prostheses «BioLAB» implanted in aortic position was 91.1±2.9%, 85.3±6.1% and 85.3±6.1%, respectively. 5-, 10- and 15-years survival among those who received mitral valve replacement was 72.31%±5.56%, 55.18%±6.61%, and 22.77%±12.13%, respectively. There were no cases of redo surgeries for valve tissue degeneration among the recipients of stented and stentless aortic valve prostheses within the follow-up. 10-, 12- and 15-years freedom from mitral valve degeneration was 61.08±7.32%, 50.21±9.56%, and 43.6±10.65%. Conclusion Stented xenopericardial bioprostheses «BioLAB» implanted in the aortic position provide good and encouraging hemodynamic results in the long-term period time. There were no signs of tissue degeneration of the stented heart valves within the 10-years follow-up. Similar results were obtained for the stentless bioprosthesis within the 7-years follow-up. The period of 8.5 years after mitral valve replacement with «BioLAB» is critical for tissue degeneration of bioprosthesis.


Sign in / Sign up

Export Citation Format

Share Document